Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension

Objective: To investigate the effect of the doxazosin gastrointestinal therapeutic system (GITS) on the 24 h blood pressure (BP) profile by ambulatory blood pressure measurements (ABPM) in patients with stage 1 to stage 2 primary hypertension. - Methods and results: Seventeen hypertensive pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Lemmer, Björn (Author) , Nold, Gudrun (Author)
Format: Article (Journal)
Language:English
Published: 2003
In: Blood pressure monitoring
Year: 2003, Volume: 8, Issue: 3, Pages: 119-125
ISSN:1473-5725
DOI:10.1097/00126097-200306000-00005
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/00126097-200306000-00005
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/bpmonitoring/Fulltext/2003/06000/Effect_of_doxazosin_GITS_on_24_hour_blood_pressure.5.aspx
Get full text
Author Notes:Björn Lemmer and Gudrun Nold

MARC

LEADER 00000caa a2200000 c 4500
001 1795981938
003 DE-627
005 20230426163703.0
007 cr uuu---uuuuu
008 220317s2003 xx |||||o 00| ||eng c
024 7 |a 10.1097/00126097-200306000-00005  |2 doi 
035 |a (DE-627)1795981938 
035 |a (DE-599)KXP1795981938 
035 |a (OCoLC)1341446147 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lemmer, Björn  |d 1942-  |e VerfasserIn  |0 (DE-588)10728605X  |0 (DE-627)623794632  |0 (DE-576)32156345X  |4 aut 
245 1 0 |a Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension  |c Björn Lemmer and Gudrun Nold 
264 1 |c 2003 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.03.2022 
520 |a Objective: To investigate the effect of the doxazosin gastrointestinal therapeutic system (GITS) on the 24 h blood pressure (BP) profile by ambulatory blood pressure measurements (ABPM) in patients with stage 1 to stage 2 primary hypertension. - Methods and results: Seventeen hypertensive patients - either untreated or after a two-week run-in/washout period - underwent office and ABPM monitoring before and six weeks after an open-label once-daily morning dose of 4 mg of doxazosin GITS, an α1-adrenoceptor antagonist. Fourteen patients responded; three did not. Data analyses refers to the responders: linear analysis demonstrated statistically significant reductions from baseline in daytime, night-time, and total 24 h means for systolic BP (SBP) (7-10 mmHg) and diastolic BP (DBP) (5-10 mmHg) after treatment, with no statistically significant change in heart rate (HR). Rhythm analysis demonstrated statistically significant reductions from baseline in mean mesor (8 mmHg), maximum (6 mmHg) and minimum (10 mmHg) values in SBP, and in mean mesor (5 mmHg), maximum (7 mmHg) and minimum (5 mmHg) values in DBP. Circadian rhythm parameters in BP and HR were not significantly altered by treatment. Treatment with doxazosin GITS was well tolerated. - Conclusions: A single morning dose of doxazosin GITS at 4 mg significantly reduced ambulatory SBP and DBP throughout a 24 h period while preserving a normal 24 h BP and HR rhythm profile in stage 1 to stage 2 hypertensives. 
700 1 |a Nold, Gudrun  |e VerfasserIn  |0 (DE-588)1253632294  |0 (DE-627)1795985038  |4 aut 
773 0 8 |i Enthalten in  |t Blood pressure monitoring  |d London : Lippincott Williams & Wilkins, 1999  |g 8(2003), 3, Seite 119-125  |h Online-Ressource  |w (DE-627)324660626  |w (DE-600)2029920-5  |w (DE-576)100517536  |x 1473-5725  |7 nnas  |a Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension 
773 1 8 |g volume:8  |g year:2003  |g number:3  |g pages:119-125  |g extent:7  |a Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension 
856 4 0 |u https://doi.org/10.1097/00126097-200306000-00005  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.lww.com/bpmonitoring/Fulltext/2003/06000/Effect_of_doxazosin_GITS_on_24_hour_blood_pressure.5.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220317 
993 |a Article 
994 |a 2003 
998 |g 1253632294  |a Nold, Gudrun  |m 1253632294:Nold, Gudrun  |d 60000  |d 65400  |e 60000PN1253632294  |e 65400PN1253632294  |k 0/60000/  |k 1/60000/65400/  |p 2  |y j 
998 |g 10728605X  |a Lemmer, Björn  |m 10728605X:Lemmer, Björn  |d 60000  |d 65400  |d 60000  |e 60000PL10728605X  |e 65400PL10728605X  |e 60000PL10728605X  |k 0/60000/  |k 1/60000/65400/  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1795981938  |e 4093804540 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 17.03.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1795981938","title":[{"title":"Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension","title_sort":"Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertension"}],"person":[{"given":"Björn","family":"Lemmer","role":"aut","roleDisplay":"VerfasserIn","display":"Lemmer, Björn"},{"given":"Gudrun","family":"Nold","role":"aut","roleDisplay":"VerfasserIn","display":"Nold, Gudrun"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"id":{"issn":["1473-5725"],"eki":["324660626"],"zdb":["2029920-5"]},"origin":[{"publisherPlace":"London","dateIssuedDisp":"1999-","dateIssuedKey":"1999","publisher":"Lippincott Williams & Wilkins"}],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Blood pressure monitoring","subtitle":"an international journal devoted to research in blood pressure monitoring and variability","title_sort":"Blood pressure monitoring"}],"part":{"year":"2003","issue":"3","pages":"119-125","volume":"8","text":"8(2003), 3, Seite 119-125","extent":"7"},"pubHistory":["Nachgewiesen 4.1999 -"],"language":["eng"],"recId":"324660626","disp":"Effect of doxazosin GITS on 24-hour blood pressure profile in patients with stage 1 to stage 2 primary hypertensionBlood pressure monitoring","note":["Gesehen am 23.07.2019"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"2003","dateIssuedKey":"2003"}],"id":{"eki":["1795981938"],"doi":["10.1097/00126097-200306000-00005"]},"name":{"displayForm":["Björn Lemmer and Gudrun Nold"]}} 
SRT |a LEMMERBJOEEFFECTOFDO2003